| Clinical pharmacology of opioids for pain CE Inturrisi The Clinical journal of pain 18 (4), S3-S13, 2002 | 811 | 2002 |
| The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions RK Portenoy, KM Foley, CE Inturrisi Pain 43 (3), 273-286, 1990 | 745 | 1990 |
| Central nervous system excitatory effects of meperidine in cancer patients RF Kaiko, KM Foley, PY Grabinski, G Heidrich, AG Rogers, CE Inturrisi, ... Annals of Neurology: Official Journal of the American Neurological …, 1983 | 588 | 1983 |
| Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. D Paul, KM Standifer, CE Inturrisi, GW Pasternak Journal of Pharmacology and Experimental Therapeutics 251 (2), 477-483, 1989 | 512 | 1989 |
| Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions C Wahlestedt, E Golanov, S Yamamoto, F Yee, H Ericson, H Yoo, ... Nature 363 (6426), 260-263, 1993 | 502 | 1993 |
| Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer HH SZETO, CE INTURRISI, R HOUDE, S SAAL, J CHEIGH, ... Annals of Internal Medicine 86 (6), 738-741, 1977 | 464 | 1977 |
| The d-and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord AL Gorman, KJ Elliott, CE Inturrisi Neuroscience letters 223 (1), 5-8, 1997 | 459 | 1997 |
| Morphine-6-glucuronide, a potent mu agonist GW Pasternak, RJ Bodnar, JA Clark, CE Inturrisi Life sciences 41 (26), 2845-2849, 1987 | 448 | 1987 |
| National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease OW Brawley, LJ Cornelius, LR Edwards, VN Gamble, BL Green, C Inturrisi, ... Annals of internal medicine 148 (12), 932-938, 2008 | 384 | 2008 |
| Sublingual absorption of selected opioid analgesics DS Weinberg, CE Inturrisi, B Reidenberg, DE Moulin, TJ Nip, ... Clinical Pharmacology & Therapeutics 44 (3), 335-342, 1988 | 380 | 1988 |
| The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but … K Elliott, N Minami, YA Kolesnikov, GW Pasternak, CE Inturrisi Pain 56 (1), 69-75, 1994 | 348 | 1994 |
| d-Methadone blocks morphine tolerance andN-methyl-D-aspartate-induced hyperalgesia AM Davis, CE Inturrisi Journal of Pharmacology and Experimental Therapeutics 289 (2), 1048-1053, 1999 | 337 | 1999 |
| Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain CE Inturrisi, WA Colburn, RF Kaiko, RW Houde, KM Foley Clinical Pharmacology & Therapeutics 41 (4), 392-401, 1987 | 309 | 1987 |
| Treatment of opioid‐induced constipation with oral naloxone: a pilot study JA Culpepper‐Morgan, CE Inturrisi, RK Portenoy, K Foley, RW Houde, ... Clinical Pharmacology & Therapeutics 52 (1), 90-95, 1992 | 301 | 1992 |
| The pharmacokinetics of heroin in patients with chronic pain CE Inturrisi, MB Max, KM Foley, M Schultz, SU Shin, RW Houde New England Journal of Medicine 310 (19), 1213-1217, 1984 | 300 | 1984 |
| Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. PJ Tiseo, CE Inturrisi Journal of Pharmacology and Experimental Therapeutics 264 (3), 1090-1096, 1993 | 285 | 1993 |
| β-Endorphin: Analgesic and hormonal effects in humans KM Foley, IA Kourides, CE Inturrisi, RF Kaiko, CG Zaroulis, JB Posner, ... Proceedings of the National Academy of Sciences 76 (10), 5377-5381, 1979 | 275 | 1979 |
| Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society R Chou, RA Cruciani, DA Fiellin, P Compton, JT Farrar, MC Haigney, ... The Journal of Pain 15 (4), 321-337, 2014 | 265 | 2014 |
| Evidence from opiate binding studies that heroin acts through its metabolites CE Inturrisi, M Schultz, S Shin, JG Umans, L Angel, EJ Simon Life Sciences 33, 773-776, 1983 | 258 | 1983 |
| Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. RK Portenoy, MA Southam, SK Gupta, J Lapin, M Layman, CE Inturrisi, ... Anesthesiology 78 (1), 36-43, 1993 | 245 | 1993 |
